Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor

被引:267
作者
Kalkhoven, E [1 ]
Valentine, JE [1 ]
Heery, DM [1 ]
Parker, MG [1 ]
机构
[1] Imperial Canc Res Fund, Mol Endocrinol Lab, London WC2A 3PX, England
关键词
activation function; co-activator; oestrogen receptor; SRC1;
D O I
10.1093/emboj/17.1.232
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Steroid receptor co-activator (SRC1) is one of a number of transcriptional co-activators that are capable of potentiating the activity of nuclear receptors including the oestrogen receptor (ER), Here we report that two isoforms, SRC1a and SRC1e, which diverge at their C-termini, are functionally distinct as they differ in their abilities to enhance the activity of the ER in intact cells, SRC1e enhanced the ability of the ER to stimulate transcription to a greater extent than SRC1a, which had negligible effects on certain promoters. To elucidate the basis of this functional difference, ve compared the nuclear receptor-binding properties and mapped the transcriptional activation domains in the two SRC1 isoforms, Both isoforms share a triplet of nuclear receptor-binding moths (LXXLL moths) for binding to functional ER dimers, and an activation domain which co-localizes with the CBP-binding domain, while SRC1a contains a unique LXXLL moth in its C-terminus. Although this LXXLL motif increases the affinity for the ER in vitro, it does not appear to be responsible for the functional difference between the two isoforms, This difference is due to a second activation domain that is CBP independent and is suppressed in the SRC1a isoform. Thus, SRC1 exists as functionally distinct isoforms which are likely to play different roles in ER-mediated transcription.
引用
收藏
页码:232 / 243
页数:12
相关论文
共 68 条
  • [1] ADAN RAH, 1992, J BIOL CHEM, V267, P3771
  • [2] AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
    Anzick, SL
    Kononen, J
    Walker, RL
    Azorsa, DO
    Tanner, MM
    Guan, XY
    Sauter, G
    Kallioniemi, OP
    Trent, JM
    Meltzer, PS
    [J]. SCIENCE, 1997, 277 (5328) : 965 - 968
  • [3] The CBP co-activator is a histone acetyltransferase
    Bannister, AJ
    Kouzarides, T
    [J]. NATURE, 1996, 384 (6610) : 641 - 643
  • [4] CHARACTERIZATION OF THE LIGAND-DEPENDENT TRANSACTIVATION DOMAIN OF THYROID-HORMONE RECEPTOR
    BARETTINO, D
    RUIZ, MDMV
    STUNNENBERG, HG
    [J]. EMBO JOURNAL, 1994, 13 (13) : 3039 - 3049
  • [5] Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
    Baur, EV
    Zechel, C
    Heery, D
    Heine, MJS
    Garnier, JM
    Vivat, V
    LeDouarin, B
    Gronemeyer, H
    Chambon, P
    Losson, R
    [J]. EMBO JOURNAL, 1996, 15 (01) : 110 - 124
  • [6] STEROID-HORMONE RECEPTORS - MANY ACTORS IN SEARCH OF A PLOT
    BEATO, M
    HERRLICH, P
    SCHUTZ, G
    [J]. CELL, 1995, 83 (06) : 851 - 857
  • [7] CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA
    BOURGUET, W
    RUFF, M
    CHAMBON, P
    GRONEMEYER, H
    MORAS, D
    [J]. NATURE, 1995, 375 (6530) : 377 - 382
  • [8] Molecular basis of agonism and antagonism in the oestrogen receptor
    Brzozowski, AM
    Pike, ACW
    Dauter, Z
    Hubbard, RE
    Bonn, T
    Engstrom, O
    Ohman, L
    Greene, GL
    Gustafsson, JA
    Carlquist, M
    [J]. NATURE, 1997, 389 (6652) : 753 - 758
  • [9] Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
    Bunone, G
    Briand, PA
    Miksicek, RJ
    Picard, D
    [J]. EMBO JOURNAL, 1996, 15 (09) : 2174 - 2183
  • [10] INTERACTION OF PROTEINS WITH TRANSCRIPTIONALLY ACTIVE ESTROGEN-RECEPTORS
    CAVAILLES, V
    DAUVOIS, S
    DANIELIAN, PS
    PARKER, MG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) : 10009 - 10013